Letter of Transmittal January 15, 2013 Mr. Mohammad A bdul Momen, Professor Institute of Business Administration Uniersity of !ha"a !ha"a 1000, Ban#ladesh !ear Mr. Momen In $om%lian$e &ith the re'uirements of the (inan$ial A$$ountin# 2 $ourse, &e, the members of )rou% *, are %leased to submit the follo&in# re%ort on the finan$ial analysis +'uare %harma$euti$als in this industry. After $onsultin# a number of a$$ountin# tet boo"s alon# &ith the one re$ommended by you in this $ourse, &e &ere able to use the three ma-or tools of analyin# finan$ial data/ hori ont al , erti$ al , and ra ti o anal ysi s. he an nual fi na n$ ia l re %ort s of +'ua re Pharma$euti$als td. &ere aailable on the internet. e further resear$hed by surfin# online &here &e &ere able to #ather a lot of information on Ban#ladeshs oerall e$onomy as &ell as in the industry of %harma$euti$als. e than" you for this o%%ortunity to &rite a re%ort based on a detailed finan$ial analysis of an industry and a s%e$ifi$ $om%any from the %ers%e$t ie of a ban"er. 4learl y, the e%erien$e of %uttin# su$h a re%ort to#ether &ill add to our understandin# of finan$e and hel% on our -ourney as business %ersons. +in$erely members of )rou% *6, +haila 7usrat Aurin 809 ashfia :a&na" Ani"a 80; ari'ue Mahmud Pasha 825 +hadman +a"ib Ani" 835 Aanisha Mahmood 85; Pa#e < 1
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 1/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 2/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 3/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 4/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 5/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 6/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 7/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 8/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 9/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 10/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 11/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 12/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 13/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 14/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 15/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 16/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 17/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 18/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 19/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 20/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 21/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 22/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 23/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 24/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 25/26
8/9/2019 Fin Analysis of Square Pharmaceuticals
http://slidepdf.com/reader/full/fin-analysis-of-square-pharmaceuticals 26/26
Related Documents
![Square Pharmaceuticals Limited [12-15AM]](https://static.cupdf.com/doc/110x72/5695d38f1a28ab9b029e60c0/square-pharmaceuticals-limited-12-15am.jpg)